Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

Compare

1.420

+0.100 (7.58%)

At close: Feb 6, 2026, 4:00 PM EST

1.408

-0.012 (-0.82%)

After-hours: Feb 6, 2026, 7:59 PM EST

Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	86.12	227.38	239.57	382.44	310.34	153.3
Short-Term Investments	281.29	360.64	-	-	-	-
Cash & Short-Term Investments	367.41	588.02	239.57	382.44	310.34	153.3
Cash Growth	-44.08%	145.45%	-37.36%	23.23%	102.44%	-27.22%
Accounts Receivable	32.6	0.95	1.05	0.15	0.07	-
Other Receivables	58.76	47.3	23.5	28.82	26.18	29.69
Receivables	91.36	48.24	24.54	28.98	26.25	29.69
Inventory	27.72	4.14	-	-	-	-
Prepaid Expenses	23.21	15.21	8.64	12.34	8.71	10.21
Restricted Cash	1.5	1.43	0.77	0.33	0.34	0.79
Other Current Assets	3.38	3.89	1.79	1.7	1.31	3.01
Total Current Assets	514.58	660.93	275.3	425.77	346.95	196.98
Property, Plant & Equipment	123.48	105.05	95.65	58.42	52.32	89.68
Other Intangible Assets	20.28	12.37	-	-	0.07	0.16
Long-Term Deferred Tax Assets	2.39	3.24	3.06	2.08	1.83	1.75
Other Long-Term Assets	1.22	1.13	1.36	4.01	4.4	5.66
Total Assets	661.95	782.73	375.38	490.27	405.56	294.24
Accounts Payable	10.97	1.97	0.1	0.53	0.43	2.26
Accrued Expenses	49.9	51.8	39.05	40.4	23.51	27.08
Current Portion of Leases	4.83	3	5.05	5.04	4.45	3.59
Other Current Liabilities	2.36	3.98	0.53	0.39	0.16	0.7
Total Current Liabilities	83.07	60.74	44.74	46.37	28.55	33.63
Long-Term Debt	251.95	244.6	170.9	125.9	47.02	-
Long-Term Leases	61.01	49.63	47.91	19.22	16.55	50.57
Other Long-Term Liabilities	0.47	0.43	0.36	0.12	0.13	-
Total Liabilities	396.5	355.4	263.91	191.6	92.24	84.21
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,567	1,556	1,019	1,008	843.11	595.02
Retained Earnings	-1,296	-1,099	-878.56	-670.18	-521.34	-379.24
Comprehensive Income & Other	-4.8	-29.06	-28.87	-38.78	-8.45	-5.74
Shareholders' Equity	265.45	427.33	111.47	298.67	313.32	210.03
Total Liabilities & Equity	661.95	782.73	375.38	490.27	405.56	294.24
Total Debt	325.18	297.23	223.87	150.16	68.01	54.16
Net Cash (Debt)	42.23	290.79	15.7	232.28	242.32	99.14
Net Cash Growth	-88.13%	1752.19%	-93.24%	-4.15%	144.43%	-46.24%
Net Cash Per Share	0.16	1.14	0.09	2.45	3.36	1.92
Filing Date Shares Outstanding	266.14	266.13	265.93	173.07	90.91	52.35
Total Common Shares Outstanding	266.14	266.12	174.1	173.07	90.91	52.35
Working Capital	431.51	600.19	230.57	379.41	318.4	163.35
Book Value Per Share	1.00	1.61	0.64	1.73	3.45	4.01
Tangible Book Value	245.17	414.95	111.47	298.67	313.26	209.87
Tangible Book Value Per Share	0.92	1.56	0.64	1.73	3.45	4.01
Machinery	55.34	50.42	38.37	35.98	38.92	27.76
Construction In Progress	39.15	19.64	12.54	13.19	2.44	14.32
Leasehold Improvements	15.14	14.12	12.73	11.69	14.9	10.63

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q